Last updated: October 14, 2024
Sponsor: Meir Hospital, Kfar Saba, Israel
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hemorrhage
Treatment
femoral neck CRIF
Clinical Study ID
NCT06644976
mmc000723
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery
Exclusion
Exclusion Criteria:
under 18 y.o
anti platelet therapy (aspirin is not included)
creatinine clearance under 50
active anti cancer therapy
ITP patients
non capable of making inform consent
patients which decide not to proceed with the expeirment
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: femoral neck CRIF
Phase:
Study Start date:
August 20, 2024
Estimated Completion Date:
December 31, 2025
Connect with a study center
Meir Hospital
Kfar Saba, 4428164
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.